Utah Medical Products (UTMD) Shares Outstanding (Weighted Average) (2010 - 2026)

Utah Medical Products' Shares Outstanding (Weighted Average) history runs 17 years deep, the most recent figure standing at $3.2 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) fell 3.78% year-over-year to $3.2 million; the TTM figure through Mar 2026 stood at $3.2 million (down 3.78% YoY), while the FY2025 annual figure was $3.2 million, down 7.51% from the prior year.
• Shares Outstanding (Weighted Average) was $3.2 million for Q1 2026 at Utah Medical Products, down from $3.2 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $3.7 million in Q1 2022 to a low of $3.2 million in Q1 2026.
• Historically, Shares Outstanding (Weighted Average) has averaged $3.5 million across 5 years, with a median of $3.6 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Weighted Average) advanced 0.3% in 2022, then retreated 9.3% in 2025.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $3.6 million in 2022, then declined by 0.22% to $3.6 million in 2023, then declined by 3.47% to $3.5 million in 2024, then fell by 7.51% to $3.2 million in 2025, then fell by 1.7% to $3.2 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $3.2 million (Q1 2026), $3.2 million (Q4 2025), and $3.2 million (Q3 2025), per Business Quant data.